Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Inflammopharmacology ; 32(1): 537-550, 2024 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-37620622

RESUMEN

Sepsis is a complex, multifactorial syndrome characterized by a dysregulated host response to infection, leading to severe organ dysfunction and high mortality rates among critically ill patients. Hypovitaminosis C and vitamin C deficiency are frequently observed in septic patients, prompting interest in the potential therapeutic role of ascorbic acid. Although intravenous administration of ascorbic acid has been investigated in multiple clinical trials for sepsis treatment, the specific immunomodulatory mechanisms underlying its effects remain elusive. This study aimed to investigate the protective effects of high-dose ascorbic acid on experimental sepsis. Results show that intravenous administration of high-dose ascorbic acid (250 mg/kg) attenuated sepsis-induced organ dysfunctions in a cecal ligation and puncture (CLP)-induced septic mouse model. Ascorbic acid improved splenic cell apoptosis and increased the number of CD3+ T cells in septic mice induced by CLP. Furthermore, ascorbic acid downregulated PD-L1 expression in livers, reduced PD-1 expression in spleens, and inhibited the phosphorylation of STAT1 at Y701 in multiple organs of CLP-induced septic mice. The in vitro experiments also revealed that 800 µM ascorbic acid suppressed STAT1 phosphorylation and inhibited lipopolysaccharide (LPS) and IFN-γ-induced PD-L1 expression in macrophages. These findings suggest that ascorbic acid prevents sepsis-associated organ dysfunction through the p-STAT1/PD-L1 signaling pathway. Our study provides new insights into the potential therapeutic use of ascorbic acid in sepsis.


Asunto(s)
Antineoplásicos , Sepsis , Humanos , Animales , Ratones , Antígeno B7-H1 , Insuficiencia Multiorgánica , Fosforilación , Sepsis/tratamiento farmacológico , Ácido Ascórbico/farmacología , Factor de Transcripción STAT1
2.
J Environ Manage ; 294: 113001, 2021 Sep 15.
Artículo en Inglés | MEDLINE | ID: mdl-34111595

RESUMEN

Yellow phosphorous flue dust (YPFD) is a solid waste produced by the yellow phosphorus industry that contains heavy metals such as zinc (Zn) and lead (Pb), causing environmental damage. In this work, a vacuum metallurgy method is proposed to separate and recover Zn and Pb from solid waste YPFD. Under optimized conditions of 1173 K, 30 wt% reductant dosage, 60 min, and 5-10 Pa, the pre-separation of Zn and Pb was realized and the recovery rates of Zn and Pb reached 92.47% and 99.78%, respectively. In addition, gallium (Ga) remained in the residue with little loss, and then recovered by raising the reaction temperature to 1323 K. The recovery rates of Ga reached 87.57%. The principle of metal volatilization under vacuum at different temperatures was also clarified. The thermodynamic calculations of the carbothermal reduction reaction of metal oxides under vacuum were carried out. The analysis of the product obtained at 1173 K showed that Zn and Pb mainly existed in the form of elemental or simple compounds. At 1323 K, Ga in the residue was highly enriched in the condensation zone, which is conducive for the subsequent purification. The whole process is short, there is no waste water, low levels of pollution of emitted, and the technology provides a clean and sustainable way to reuse YPFD.


Asunto(s)
Metales Pesados , Zinc , Polvo , Plomo , Metalurgia , Metales Pesados/análisis , Fósforo , Vacio , Zinc/análisis
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA